Dr. Mike Stebbins is Senior Vice President at Advanced Technology International (ATI), where he leads efforts to advance the U.S. bioeconomy through innovation, public-private partnerships, and strategic investment. A recognized thought leader in technology development and health security, Dr. Stebbins has facilitated more than $12 billion in federal investments and oversees ATI’s $60 billion Medical and Health Security portfolio, supporting HHS and DoD initiatives that strengthen national preparedness and response.
Dr. Stebbins is known for bridging government mission needs with industry, academia, and manufacturing, driving the rapid development and delivery of vaccines, treatments, and advanced biomanufacturing capabilities. His leadership of key platforms, including the Rapid Response Partnership Vehicle (RRPV), Biopharmaceutical Manufacturing Preparedness Consortium (BioMaP), and the Medical CBRN Defense Consortium (MCDC), has been instrumental in building a resilient, scalable bioindustrial base.
Championing a shift from reactive crisis response to sustained, agile preparedness, Dr. Stebbins brings deep expertise in ecosystem convening, stakeholder engagement, and portfolio alignment. He holds a Ph.D. in analytical chemistry from the University of Tennessee, Knoxville, and regularly engages with leaders across sectors to shape the future of the bioeconomy.